"Somebody to Say 'Come On We Can Sort This'": A Qualitative Study of Primary Care Consultation Among Older Adults With Symptomatic Foot Osteoarthritis (2013)
Journal Article
Thomas, M., Moore, A., Roddy, E., & Peat, G. (2013). "Somebody to Say 'Come On We Can Sort This'": A Qualitative Study of Primary Care Consultation Among Older Adults With Symptomatic Foot Osteoarthritis. Arthritis Care and Research, 65(12), 2051 - 2055. https://doi.org/10.1002/acr.22073

Objective
To examine the experiences of primary care consultation among older adults with symptomatic foot osteoarthritis (OA).

Methods
Eleven participants (6 women and 5 men) ages 56–80 years who had radiographically confirmed symptomatic foot... Read More about "Somebody to Say 'Come On We Can Sort This'": A Qualitative Study of Primary Care Consultation Among Older Adults With Symptomatic Foot Osteoarthritis.

Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro (2013)
Journal Article
(2013). Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro. Antimicrobial Agents and Chemotherapy, 5612-5618. https://doi.org/10.1128/AAC.01421-13

Rilpivirine is a nonnucleoside reverse transcriptase inhibitor approved for treatment of HIV-1 infection in antiretroviral-naive adult patients. Potential interactions with drug transporters have not been fully investigated. Transport by and inhibiti... Read More about Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro.

Predicting intestinal absorption of raltegravir using a population-based ADME simulation (2013)
Journal Article
(2013). Predicting intestinal absorption of raltegravir using a population-based ADME simulation. Journal of Antimicrobial Chemotherapy, 1627-1634. https://doi.org/10.1093/jac/dkt084

Objectives
Raltegravir pharmacokinetics (PK) show high intra- and inter-patient variability and are also influenced by co-administered substances that alter the gastrointestinal tract environment, such as pH-altering or metal-containing agents. The... Read More about Predicting intestinal absorption of raltegravir using a population-based ADME simulation.

Antimalarial pharmacology and therapeutics of atovaquone (2013)
Journal Article
(2013). Antimalarial pharmacology and therapeutics of atovaquone. Journal of Antimicrobial Chemotherapy, 977-985. https://doi.org/10.1093/jac/dks504

Atovaquone is used as a fixed-dose combination with proguanil (Malarone) for treating children and adults with uncomplicated malaria or as chemoprophylaxis for preventing malaria in travellers. Indeed, in the USA, between 2009 and 2011, Malarone pres... Read More about Antimalarial pharmacology and therapeutics of atovaquone.